| Lactose (India) Ltd | 162 Cr. | 129 | 247/84.3 | 35.9 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,538 Cr. | 417 | 479/192 | 94.0 | 24.3 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.9 Cr. | 47.0 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 41.5 Cr. | 28.3 | 29.1/17.0 | 98.8 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 59.1 Cr. | 78.5 | 134/75.4 | 16.0 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 54,221 Cr. | 1,921 | 2,286/1,275 | 21.6 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 333 Cr. | 13.7 | 19.5/10.8 | 20.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 882 Cr. | 1,868 | 1,971/635 | 30.5 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 106 Cr. | 21.1 | 32.0/16.8 | 28.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 838 Cr. | 285 | 449/219 | 7.48 | 133 | 0.88 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.39 Cr. | 3.37 | 9.28/2.11 | 4.77 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 404 Cr. | 416 | 477/138 | 61.0 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,581 Cr. | 1,050 | 1,565/1,038 | 41.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.24/0.26 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 42.5 Cr. | 17.7 | 26.3/6.60 | 43.8 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.5 Cr. | 10.4 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 175 Cr. | 490 | 859/443 | 9.91 | 596 | 0.31 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 82.5 Cr. | 82.5 | 92.5/26.1 | 156 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,016 Cr. | 1,440 | 2,452/1,345 | 46.7 | 174 | 0.74 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 18.4 Cr. | 40.4 | 88.7/36.1 | 40.1 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 14.9 Cr. | 5.95 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 15.7 Cr. | 105 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 52.2 Cr. | 95.4 | 95.4/9.41 | 36.0 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 29.2 Cr. | 38.7 | 80.0/37.1 | 47.1 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.22 Cr. | 20.7 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,894 Cr. | 571 | 1,028/492 | 28.1 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.4 Cr. | 20.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.4 Cr. | 22.6 | 43.7/17.4 | 49.8 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 93,182 Cr. | 2,259 | 3,055/2,115 | 55.9 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 224 Cr. | 389 | 524/241 | 23.0 | 123 | 1.16 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.2 Cr. | 40.5 | 62.6/26.7 | 90.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 71,317 Cr. | 1,227 | 1,365/994 | 20.8 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 152 Cr. | 244 | 303/159 | 145 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 772 Cr. | 76.9 | 123/74.0 | 19.9 | 32.6 | 1.95 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 33.2 Cr. | 25.4 | 50.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,618 Cr. | 1,784 | 1,902/919 | 65.3 | 173 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.17 Cr. | 0.63 | 1.45/0.55 | 104 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 222 Cr. | 29.0 | 68.0/28.4 | 14.2 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.38 Cr. | 9.20 | 23.8/9.20 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 134 Cr. | 5.67 | 6.57/2.82 | 311 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 63,529 Cr. | 29,965 | 37,000/25,260 | 42.1 | 1,888 | 1.58 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,353 Cr. | 708 | 972/550 | 26.5 | 226 | 0.70 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 261 Cr. | 91.9 | 100/31.3 | 73.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,763 Cr. | 1,554 | 1,740/558 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 20,760 Cr. | 1,279 | 1,870/1,110 | 378 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 834 Cr. | 239 | 330/154 | 19.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 937 Cr. | 699 | 729/270 | 14.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,290 Cr. | 469 | 875/438 | 22.6 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,587 Cr. | 1,114 | 1,595/991 | 22.5 | 768 | 0.90 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,26,954 Cr. | 3,751 | 3,882/2,886 | 58.6 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 992 Cr. | 108 | 304/98.0 | | 41.3 | 0.47 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,485 Cr. | 15.8 | 24.0/14.1 | 23.6 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 21,822 Cr. | 570 | 1,360/556 | 63.5 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,018 Cr. | 176 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,34,290 Cr. | 1,805 | 1,910/1,547 | 37.6 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,332 Cr. | 524 | 886/441 | 364 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,016 Cr. | 323 | 329/175 | 37.2 | 81.2 | 0.12 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 444 Cr. | 1,438 | 1,680/956 | 23.8 | 683 | 0.10 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,806 Cr. | 348 | 502/265 | 44.0 | 125 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,566 Cr. | 220 | 260/111 | 129 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,173 Cr. | 4,418 | 6,718/4,146 | 27.5 | 340 | 2.65 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,699 Cr. | 2,240 | 2,725/1,772 | 33.2 | 335 | 0.90 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,667 Cr. | 5,824 | 6,739/4,904 | 31.5 | 373 | 2.15 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 169 Cr. | 48.0 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,797 Cr. | 4,983 | 5,993/3,701 | 32.3 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 111 Cr. | 90.6 | 348/81.0 | 11.5 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,349 Cr. | 382 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,433 Cr. | 874 | 1,998/604 | 84.8 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,284 Cr. | 16,610 | 19,748/10,060 | 109 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 339 Cr. | 15.1 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,603 Cr. | 927 | 1,505/660 | 10.8 | 483 | 0.65 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,427 Cr. | 44.4 | 91.7/41.7 | 32.1 | 21.8 | 0.45 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,669 Cr. | 192 | 359/162 | 24.6 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 51.8 Cr. | 32.8 | 130/32.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 298 Cr. | 83.1 | 177/78.9 | 146 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 94,537 Cr. | 2,072 | 2,403/1,774 | 21.9 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,036 Cr. | 516 | 980/490 | 13.0 | 357 | 0.35 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 52,970 Cr. | 984 | 1,034/501 | 77.6 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 945 Cr. | 911 | 1,235/596 | 19.2 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 136 Cr. | 65.4 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 649 Cr. | 134 | 227/123 | 36.9 | 104 | 2.24 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 620 Cr. | 354 | 500/265 | 22.5 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,637 Cr. | 1,106 | 1,265/802 | 35.5 | 414 | 0.45 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,831 Cr. | 1,775 | 1,952/1,303 | 38.7 | 243 | 0.87 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,353 Cr. | 203 | 328/193 | 30.9 | 38.0 | 1.23 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 35,634 Cr. | 1,404 | 1,758/1,168 | 36.0 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,684 Cr. | 91.7 | 127/57.5 | 23.1 | 59.7 | 0.87 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 777 Cr. | 95.4 | 124/67.2 | 26.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,398 Cr. | 260 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,720 Cr. | 221 | 465/217 | 269 | 96.9 | 0.63 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,408 Cr. | 1,656 | 2,768/1,243 | 32.1 | 397 | 0.42 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,694 Cr. | 369 | 498/285 | 68.0 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,286 Cr. | 549 | 628/412 | 26.0 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,283 Cr. | 1,924 | 2,286/1,275 | 21.6 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,022 Cr. | 2,482 | 3,516/1,921 | 44.1 | 101 | 1.69 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,628 Cr. | 1,799 | 2,131/1,200 | 25.6 | 610 | 1.00 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,845 Cr. | 420 | 530/359 | 30.4 | 149 | 1.19 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 22,009 Cr. | 1,616 | 1,910/1,097 | 52.9 | 227 | 0.45 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,048 Cr. | 1,246 | 1,406/1,020 | 18.0 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,822 Cr. | 244 | 322/178 | 25.6 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,22,943 Cr. | 1,522 | 1,673/1,310 | 22.6 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,562 Cr. | 1,915 | 2,641/1,551 | 24.7 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 315 Cr. | 107 | 203/95.2 | 22.5 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,761 Cr. | 166 | 191/105 | 16.1 | 107 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 58.9 Cr. | 36.9 | 72.0/35.5 | 20.7 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 53,358 Cr. | 399 | 425/291 | 112 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,675 Cr. | 1,660 | 2,190/1,430 | 37.0 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 120 Cr. | 76.4 | 132/73.3 | 17.6 | 49.2 | 1.57 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 373 Cr. | 158 | 205/67.8 | 35.2 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,641 Cr. | 9,057 | 10,691/6,301 | 98.0 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,983 Cr. | 686 | 843/544 | 35.0 | 118 | 0.69 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 166 Cr. | 79.0 | 137/75.6 | 8.84 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,835 Cr. | 5,757 | 5,868/4,492 | 29.3 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,907 Cr. | 911 | 1,124/725 | 28.2 | 271 | 1.21 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 451 Cr. | 790 | 1,540/763 | | 690 | 0.64 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,714 Cr. | 2,538 | 3,116/2,022 | 32.6 | 345 | 1.13 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,520 Cr. | 314 | 412/258 | 23.9 | 133 | 1.66 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,052 Cr. | 444 | 575/312 | 21.3 | 147 | 0.23 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,356.00 Cr | 1,182.92 | | 52.67 | 202.40 | 0.35% | 16.24% | 14.95% | 6.10 |